Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $28.29 in the last session, down -1.91% from day before closing price of $28.84. In other words, the price has decreased by -$1.91 from its previous closing price. On the day, 0.95 million shares were traded. ZLAB stock price reached its highest trading level at $28.83 during the session, while it also had its lowest trading level at $27.81.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.12. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55.
BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 02 ’25 when Chen Yajing sold 456 shares for $34.25 per share. The transaction valued at 15,617 led to the insider holds 17,184 shares of the business.
Chen Yajing bought 456 shares of ZLAB for $15,617 on Oct 02 ’25. On Sep 10 ’25, another insider, Smiley Joshua L, who serves as the insider of the company, bought 10,000 shares for $28.91 each. As a result, the insider paid 289,100 and bolstered with 86,604 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3152901888 and an Enterprise Value of 30565718016. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.36 while its Price-to-Book (P/B) ratio in mrq is 3.93. Its current Enterprise Value per Revenue stands at 71.449 whereas that against EBITDA is -130.704.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.11, which has changed by 0.0103571415 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $23.82. The 50-Day Moving Average of the stock is -13.44%, while the 200-Day Moving Average is calculated to be -13.30%.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 727.94K shares per day over the past 3-months and 639250 shares per day over the past 10 days. A total of 109.91M shares are outstanding, with a floating share count of 109.00M. Insiders hold about 2.04% of the company’s shares, while institutions hold 37.42% stake in the company. Shares short for ZLAB as of 1759190400 were 4899193 with a Short Ratio of 6.73, compared to 1756425600 on 4742504. Therefore, it implies a Short% of Shares Outstanding of 4899193 and a Short% of Float of 4.99.
Earnings Estimates
The stock of Zai Lab Limited ADR (ZLAB) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.1, with high estimates of $0.08 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$0.97 and -$1.78 for the fiscal current year, implying an average EPS of -$1.36. EPS for the following year is $0.28, with 10.0 analysts recommending between $0.8 and -$0.33.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $150.24M. It ranges from a high estimate of $158M to a low estimate of $138.25M. As of. The current estimate, Zai Lab Limited ADR’s year-ago sales were $102.27MFor the next quarter, 7 analysts are estimating revenue of $185.26M. There is a high estimate of $205.45M for the next quarter, whereas the lowest estimate is $160.26M.
A total of 16 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $579M, while the lowest revenue estimate was $519.76M, resulting in an average revenue estimate of $560.01M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $850.62M in the next fiscal year. The high estimate is $962M and the low estimate is $704.23M.
